Skip to content

Oncolytics Biotech Inc Price, Chart & Factor Analysis

Free Data & Analytics Access
Oncolytics Biotech Inc · E.ONC.TO · Canada
Use symbol E.ONC.TO in our API & Excel add-in to retrieve this data ↓
14.90
(-0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 5,761.72%

Oncolytics Biotech Inc Forecast

Oncolytics Biotech Inc short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 5,761.7% a year, a typical one-standard-deviation range is -106.03–135.83 over a week, -232.93–262.73 over a month and -843.60–873.40 over a year. (Signals as of 1 Nov 2026.)

Oncolytics Biotech Inc Price Chart

MacroFinance.ai

Oncolytics Biotech Inc Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Oncolytics Biotech Inc
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Oncolytics Biotech Inc
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Oncolytics Biotech Inc
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Oncolytics Biotech Inc, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Oncolytics Biotech Inc

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Statistical Distribution of Returns

Plus

How Oncolytics Biotech Inc’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Oncolytics Biotech Inc behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Oncolytics Biotech Inc (Canada)

Oncolytics Biotech Inc is a listed security in Canada. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on BeiGene, Ltd.

Frequently asked questions

What is Oncolytics Biotech Inc?
Oncolytics Biotech Inc is a listed security in Canada. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns and free historical data.
What is the latest Oncolytics Biotech Inc price?
The latest close is 14.9 (1 Nov 2026), -0.01% on the day. The price at the top of the page refreshes during the trading day.
Is Oncolytics Biotech Inc in an uptrend?
As of 1 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Oncolytics Biotech Inc?
20-day realised volatility is 5761.7% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 1663.3% over a month and 811.6% over a week.
What factors affect Oncolytics Biotech Inc?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Oncolytics Biotech Inc, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
How are Oncolytics Biotech Inc returns analysed?
The Statistical Distribution of Returns section shows the distribution of Oncolytics Biotech Inc daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Oncolytics Biotech Inc historical data?
In the Free historical data section of this page: the last 10 years of Oncolytics Biotech Inc daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Oncolytics Biotech Inc historical data (last 10 years)

Browse or instantly download the last 10 years of Oncolytics Biotech Inc daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.ONC.TO&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2025-09-0314.9
2025-09-0215.1
2025-09-0116.9
2025-08-2917.4
2025-08-2818
2025-08-2718.6
2025-08-2618.6
2025-08-2518.6
2025-08-2218
2025-08-211.39
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal adenocarcinoma, and anal cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in Calgary, Canada.